PRISMASOL 2 mmol/l POTASSIUM, solution pour hémofiltration et hémodialyse

solution et solution pour hémofiltration et pour hémodialyse · hémodialyse / hémofiltration / voie extracorporelle autre

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution et solution pour hémofiltration et pour hémodialyse

Routehémodialyse / hémofiltration / voie extracorporelle autre

Ingredient entries7

CountryFrance

Product identity

At a glance

Authorisation holder: VANTIVE BELGIUM (BELGIQUE)
Authorisation status: Autorisation active
Market status: Commercialisée
Country: France
Source reference: CIS 69869147

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for PRISMASOL 2 mmol/l POTASSIUM, solution pour hémofiltration et hémodialyse
Ingredient	Strength / reference	Source role
CHLORURE DE CALCIUM DIHYDRATÉcompartiment A : solution d'électrolytes	5,145 g1000 ml	SAGroup 1
GLUCOSE ANHYDREcompartiment A : solution d'électrolytes	22 g1000 ml	SAGroup 2
ACIDE LACTIQUEcompartiment A : solution d'électrolytes	5,4 g1000 ml	SAGroup 3
CHLORURE DE MAGNÉSIUM HEXAHYDRATÉcompartiment A : solution d'électrolytes	2,033 g1000 ml	SAGroup 4
CHLORURE DE POTASSIUMcompartiment B : solution tampon	0,157 g1000 ml	SAGroup 6
BICARBONATE DE SODIUMcompartiment B : solution tampon	3,09 g1000 ml	SAGroup 1
CHLORURE DE SODIUMcompartiment B : solution tampon	6,45 g1000 ml	SAGroup 7

Pack references

Presentations (1)

2 poche(s) polyoléfine de 5000 ml bicompartimenté(e)(s)/à 2 compartiments suremballée(s)/surpochée(s)

CIP13 3400938128628

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 69869147 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source file	Retrieved	Source file modified
fr_products.txt	2026-09-17	Not supplied
fr_composition.txt	2026-09-17	Not supplied
fr_packs.txt	2026-09-17	Not supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →